BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05298423-completion@plaintrial.com
DTSTAMP:20261028T224620Z
DTSTART;VALUE=DATE:20260819
SUMMARY:Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With 
 Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus
  Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With 
 Stage III Non-small Cell Lung Cancer (MK-7684A-006) — estimated completi
 on date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05298423
URL:https://plaintrial.com/trial/NCT05298423
END:VEVENT
END:VCALENDAR